Delivery Order SPE2DB20D3101-SPE2DB21FJ3S6
- Not listed
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $7,556.17, was awarded by the Defense Logistics Agency (DLA) and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide essential medical commodities,...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of a wide range of pharmaceutical products and medical supplies to support federal healthcare programs. The award, valued at $3,405.84, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 through November 2026. This IDC serves as the...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver a wide range of pharmaceutical products and medical supplies to the U.S. government. The $13,003.97 delivery order was issued by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $23,281.60 and issued by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans'...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of pharmaceutical products and medical supplies to support various government healthcare programs, particularly within the military and veterans' healthcare systems. The contract, valued at $1,834.44, was awarded by the Defense Logistics Agency (DLA) and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. government. The award was made by the Defense Logistics Agency (DLA) through a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide essential medications,...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver a wide range of pharmaceutical products and medical supplies to the U.S. government. The award, valued at $3,007.52, is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical. This IDC, valued at up to $999,999,999.00,...
- This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under DLA's Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, covers the supply of critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. This IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,069.60, is a delivery order under the DLA's Indefinite Delivery Contract (IDC) with Amerisourcebergen, worth up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to the U.S. government. The award, with a ceiling value of $1,286.44, was issued by the Defense Logistics Agency (DLA) and is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to deliver...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB21FJ3S6Delivery Order
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of a wide range of pharmaceutical products and medical supplies to support federal government healthcare programs. The contract, awarded by the Defense Logistics Agency (DLA), is a $3,059.96 delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company is Cencora, Inc., which also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 4/26/21 |